Department of Pharmaceutical Technology, Medical University of Białystok, Bialystok, Poland.
Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden.
Drug Deliv. 2021 Dec;28(1):2278-2288. doi: 10.1080/10717544.2021.1992037.
Chitosan glutamate (gCS) spray-dried microparticles appear promising carriers to overcome challenges associated with vaginal microbicide delivery. This study aimed at elucidating the penetration and mucoadhesive behavior of developed gCS multiunit carriers with zidovudine (ZVD) as a model antiretroviral agent in contact with excised human vaginal epithelium followed with an examination of antiherpes activity in immortal human keratinocytes HaCaT and human vaginal epithelial cells VK2-E6/E7. Both ZVD dispersion and placebo microparticles served as controls. Microparticles displayed feasible (comparable to commercial vaginal product) mucoadhesive and mucoretention characteristics to isolated human vaginal tissue. penetration studies revealed that gCS increased the accumulation of active agent in the vaginal epithelium but surprisingly did not facilitate its penetration across human tissue. Finally, the obtained antiviral results demonstrated the potential of gCS as an antiherpes adjunctive, whose mode of action was related to blocking viral attachment.
壳聚糖谷氨酸(gCS)喷雾干燥微球作为克服阴道杀微生物剂传递相关挑战的有前途的载体。本研究旨在阐明开发的 gCS 多单位载体与齐多夫定(ZVD)的穿透和粘膜粘附行为,ZVD 作为一种模型抗逆转录病毒药物,与人阴道上皮接触,然后检查在永生化人角质形成细胞 HaCaT 和人阴道上皮细胞 VK2-E6/E7 中的抗疱疹活性。ZVD 分散体和安慰剂微球作为对照。微球显示出可行的(可与商业阴道产品相媲美)粘膜粘附和粘膜保留特性,可用于分离的人阴道组织。穿透研究表明,gCS 增加了活性药物在阴道上皮中的积累,但出人意料的是,它并没有促进其穿透人体组织。最后,获得的抗病毒结果表明 gCS 作为一种辅助抗疱疹的潜力,其作用模式与阻断病毒附着有关。
Antiviral Res. 2015-9-30
Eur J Pharm Sci. 2011-6-17
Polymers (Basel). 2022-10-6
Int J Biol Macromol. 2021-7-31
Front Microbiol. 2019-12-3
Drug Chem Toxicol. 2021-7